Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Transplacental pharmacokinetics of lamivudine is not affected by abc drug efflux transporters

  • In: Posters G - Pharmacokinetics (PK), Pharmacodynamics (PD) and Systems Pharmacology
  • At: PSWC, Melbourne (Australia) (2014)
  • Type: Poster
  • Poster code: PG-031
  • By: CECKOVA, Martina (Charles University, Faculty of Pharmacy, Dpt. of Pharmacology and Toxicology, Hradec kralove, Czech Republic)
  • Co-author(s): Neumanova, Zuzana (Charles University, Faculty of Pharmacy, Hradec kralove, Czech Republic)
    Reznicek, Josef (Charles University, Faculty of Pharmacy, Hradec kralove, Czech Republic)
    Cerveny, Lukas (Charles University, Faculty of Pharmacy, Hradec kralove, Czech Republic)
    Staud, Frantisek (Charles University, Faculty of Pharmacy, Hradec kralove, Czech Republic)
  • Abstract:

    Lamivudine (3TC) is an antiretroviral drug commonly used in pregnant women to prevent vertical transmission of HIV infection. Detailed knowledge on mechanisms involved in transplacental transport of the drug is necessary for evaluation of drug-drug interactions and optimization of pharmacotherapy in pregnancy. Several drug efflux transporters of..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses